HUP0101215A3 - Chrystalline form of paroxetine - Google Patents
Chrystalline form of paroxetineInfo
- Publication number
- HUP0101215A3 HUP0101215A3 HU0101215A HUP0101215A HUP0101215A3 HU P0101215 A3 HUP0101215 A3 HU P0101215A3 HU 0101215 A HU0101215 A HU 0101215A HU P0101215 A HUP0101215 A HU P0101215A HU P0101215 A3 HUP0101215 A3 HU P0101215A3
- Authority
- HU
- Hungary
- Prior art keywords
- chrystalline
- paroxetine
- chrystalline form
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
- 229960002296 paroxetine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
| GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
| GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
| PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101215A2 HUP0101215A2 (hu) | 2002-04-29 |
| HUP0101215A3 true HUP0101215A3 (en) | 2002-05-28 |
Family
ID=27269245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101215A HUP0101215A3 (en) | 1998-03-16 | 1999-03-16 | Chrystalline form of paroxetine |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1064282A1 (hu) |
| JP (1) | JP2002506865A (hu) |
| KR (1) | KR20010041947A (hu) |
| CN (1) | CN1300286A (hu) |
| AP (1) | AP2000001907A0 (hu) |
| AU (1) | AU2847199A (hu) |
| BG (1) | BG104839A (hu) |
| BR (1) | BR9908825A (hu) |
| CA (1) | CA2323896A1 (hu) |
| EA (1) | EA200000946A1 (hu) |
| HU (1) | HUP0101215A3 (hu) |
| ID (1) | ID27596A (hu) |
| IL (1) | IL138390A0 (hu) |
| NO (1) | NO20004583L (hu) |
| PL (1) | PL342931A1 (hu) |
| SK (1) | SK13622000A3 (hu) |
| TR (1) | TR200002675T2 (hu) |
| WO (1) | WO1999047519A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
| SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
-
1999
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG104839A (en) | 2001-09-28 |
| JP2002506865A (ja) | 2002-03-05 |
| PL342931A1 (en) | 2001-07-16 |
| ID27596A (id) | 2001-04-12 |
| NO20004583D0 (no) | 2000-09-14 |
| NO20004583L (no) | 2000-09-15 |
| EP1064282A1 (en) | 2001-01-03 |
| TR200002675T2 (tr) | 2000-12-21 |
| CN1300286A (zh) | 2001-06-20 |
| BR9908825A (pt) | 2000-11-21 |
| CA2323896A1 (en) | 1999-09-23 |
| WO1999047519A1 (en) | 1999-09-23 |
| HUP0101215A2 (hu) | 2002-04-29 |
| IL138390A0 (en) | 2001-10-31 |
| EA200000946A1 (ru) | 2001-02-26 |
| AU2847199A (en) | 1999-10-11 |
| KR20010041947A (ko) | 2001-05-25 |
| SK13622000A3 (sk) | 2001-03-12 |
| AP2000001907A0 (en) | 2000-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24291A (en) | Novel form of s-omeprazole | |
| IL137616A0 (en) | Variants of vegf-a | |
| GB2336364B (en) | Paroxetine salt | |
| IL137684A0 (en) | Salts of paroxetine | |
| PL342733A1 (en) | Biocement of improved properties | |
| IL140385A0 (en) | Salts of paroxetine | |
| AU1788800A (en) | Derivative of paroxetine | |
| HK1035535A1 (en) | Crystalline forms of osanetant | |
| IL138920A0 (en) | Paroxetine maleate | |
| IL138478A0 (en) | Paroxetine compositions | |
| PL345542A1 (en) | Novel salts of n-tert-butylhydroxylamine | |
| HUP9902855A3 (en) | Preparation of sterol- and stanol-esters | |
| PL344872A1 (en) | Novel formulation containing paroxetine | |
| HUP0101215A3 (en) | Chrystalline form of paroxetine | |
| PL343677A1 (en) | Paroxetine ascorbate | |
| GB9924752D0 (en) | Method of construction | |
| GB9805464D0 (en) | Construction of ioniser | |
| IL139594A0 (en) | Novel formulation containing paroxetine | |
| TW354479U (en) | Improvement of earpick | |
| TW475509U (en) | Structure of tool set | |
| TW398188U (en) | Improved structure of de-hooker | |
| TW392709U (en) | Structure of color-testing machine | |
| TW405439U (en) | Improvement of block elements | |
| SI1102747T1 (en) | Crystalline forms of osanetant | |
| HU9900075V0 (en) | Sepulchre consists of elements |